Evofem Biosciences Inc (EVFM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Evofem Biosciences Inc (EVFM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7870
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The company’s lead product candidate includes Amphora, a non-hormonal vaginal contraceptive gel for the prevention of urogenital chlamydia and gonorrhea in women. Evofem uses proprietary multi-purpose prevention technology vaginal gel to develop product candidates for multiple indications, including contraception; prevention of urogenital transmission of chlamydia and gonorrhea in women, and recurrent bacterial vaginosis. The company concentrates on women’s sexual health and reproductive care, contraception, and the prevention of sexually transmitted infections. Evofem is headquartered in San Diego, California, the US.

Evofem Biosciences Inc (EVFM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evofem Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Evofem Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Evofem Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Evofem Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Evofem Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Evofem Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Evofem Raises USD20 Million in Financing Round 10
Merger 11
Neothetics and Evofem Biosciences Merges 11
Equity Offering 13
Evofem Biosciences Raises USD39.9 Million in Public Offering of Shares 13
Evofem Biosciences Files Registration Statement to Raise up to USD57.5 Million in Public Offering of Shares 15
Evofem Biosciences Files Registration Statement to Raise up to USD122.3 Million in Public Offering of Shares 16
Evofem Raises USD25 Million in Private Placement of Shares 17
Evofem Biosciences Inc – Key Competitors 18
Evofem Biosciences Inc – Key Employees 19
Evofem Biosciences Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Evofem Biosciences Inc, Medical Equipment, Key Facts, 2017 2
Evofem Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Evofem Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Evofem Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Evofem Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Evofem Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Evofem Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Evofem Raises USD20 Million in Financing Round 10
Neothetics and Evofem Biosciences Merges 11
Evofem Biosciences Raises USD39.9 Million in Public Offering of Shares 13
Evofem Biosciences Files Registration Statement to Raise up to USD57.5 Million in Public Offering of Shares 15
Evofem Biosciences Files Registration Statement to Raise up to USD122.3 Million in Public Offering of Shares 16
Evofem Raises USD25 Million in Private Placement of Shares 17
Evofem Biosciences Inc, Key Competitors 18
Evofem Biosciences Inc, Key Employees 19

List of Figures
Evofem Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Evofem Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Evofem Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Evofem Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Evofem Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Evofem Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Evofem Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Evofem Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Evofem Biosciences Inc (EVFM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Altius Minerals Corp:企業の戦略・SWOT・財務分析
    Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report Summary Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Intas Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropo …
  • University of Alberta-製薬・医療分野:企業M&A・提携分析
    Summary University of Alberta (UALBERTA) is an educational university that provides undergraduate, international, graduate, continuing studies and open studies programs. The university offers educational programs in agricultural food and nutritional science, English and film studies, history and cla …
  • San Miguel Corporation:企業のM&A・事業提携・投資動向
    San Miguel Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's San Miguel Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Liquefied Natural Gas Ltd (LNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Liquefied Natural Gas Ltd (LNGL) is an oil and gas company that constructs, plans, manages, and operates liquefied natural gas plants. The company uses the optimized single mixed refrigerant process to develop liquefied natural gas. Its optimized single mixed refrigerant process also provide …
  • K’s Holdings Corporation:企業の戦略・SWOT・財務情報
    K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Veritone, Inc. (VERI):企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oman Refreshment Company SAOG:企業の戦略・SWOT・財務情報
    Oman Refreshment Company SAOG - Strategy, SWOT and Corporate Finance Report Summary Oman Refreshment Company SAOG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Union Pacific Corporation:企業の戦略・SWOT・財務分析
    Union Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Union Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • EnergySolutions, LLC-エネルギー分野:企業M&A・提携分析
    Summary EnergySolutions, LLC (EnergySolutions) is a nuclear services company that provides integrated services and solutions for management of radioactive material. It offers nuclear operations; characterization; decommissioning; decontamination; site closure; transportation; nuclear materials manag …
  • Cloud Live Technology Group Co. Ltd.:企業の戦略・SWOT・財務分析
    Cloud Live Technology Group Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cloud Live Technology Group Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Kimbell Royalty Partners LP (KRP):石油・ガス:M&Aディール及び事業提携情報
    Summary Kimbell Royalty Partners LP (KRP), is an oil and gas company that owns and acquires mineral and royalty interests in oil and natural gas properties throughout the US. The company has interests in the Permian Basin, Eagle Ford, Bakken Shale, San Juan Basin, Mid-Continent, East Texas, Barnett …
  • Phenex Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析
    Summary Phenex Pharmaceuticals AG (Phenex) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services which include contract screening services, NR selectivity screening and SNuRM profiling to pharmaceutical, biotechno …
  • Avcorp Industries Inc:企業の戦略・SWOT・財務情報
    Avcorp Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Avcorp Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sundaram Finance Limited:企業の戦略・SWOT・財務情報
    Sundaram Finance Limited - Strategy, SWOT and Corporate Finance Report Summary Sundaram Finance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sandoz International GmbH:企業の戦略・SWOT・財務情報
    Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report Summary Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Stora Enso Oyj:企業の戦略・SWOT・財務分析
    Stora Enso Oyj - Strategy, SWOT and Corporate Finance Report Summary Stora Enso Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hellenic Telecommunications Organization SA (HTO):企業の財務・戦略的SWOT分析
    Hellenic Telecommunications Organization SA (HTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • CITIC Ltd (267):電力:M&Aディール及び事業提携情報
    Summary CITIC Limited (CITIC) is a conglomerate company, operating in financial services, resources and energy, manufacturing, engineering contracting, real estate, and other businesses. Financial services include insurance, trust, security, and banking. Resources and energy comprises electricity ge …
  • Antitope Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The company’s iTope technology is used to identify peptides; and T cell epitope database is used for screening amino acid sequences from antibo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆